Filing Details
- Accession Number:
- 0001209191-17-023720
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-30 18:34:37
- Reporting Period:
- 2017-03-28
- Filing Date:
- 2017-03-30
- Accepted Time:
- 2017-03-30 18:34:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1412067 | Cascadian Therapeutics Inc. | CASC | Services-Commercial Physical & Biological Research (8731) | 260868560 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1506217 | A. Gwen Fyfe | C/O Cascadian Therapeutics, Inc. 2601 Fourth Ave., Suite 500 Seattle WA 98121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-03-28 | 1,666 | $4.12 | 3,332 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
